Tannia Soria

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Papillary thyroid microcarcinoma: clinical study and prognosis.

José Manuel Rodríguez, A. Moreno, Pascual Parrilla et al. · PubMed · 1997 · 54 citations

Medicine, Oncology, Surgery +16

Recurrent tuberculosis from 1992 to 2004 in a metropolitan area

J. Cacho, Ana Pérez Meixeira, Tannia Soria et al. · European Respiratory Journal · 2007 · 40 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14